Boston Therapeutics Inc (OTCQB:BTHE)

0.251
Delayed Data
As of Feb 27
 -0.0191 / -7.07%
Today’s Change
0.16
Today|||52-Week Range
0.80
-61.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues428.004.1K42.3K323.4K
 
 
 
 
 
Cost of Goods Sold398.006.4K56.9K211.1K
 
 
 
 
 
Depreciation And Amortization10.7K64.3K65.0K67.1K
 
 
 
 
 
 
Operating ExpensesGross Income-10.7K-66.5K-79.6K45.2K
 
 
 
 
 
General Expenses230.5K745.0K1.4M4.6M
 
 
 
 
 
Research And Development58.00130.0K114.0K542.5K
 
 
 
 
 
Total Operating Expenses241.6K815.6K1.5M4.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-241.2K-811.5K-1.5M-4.6M
 
 
 
 
 
Interest Expense On Debt7.1K15.7K18.4K19.7K
 
 
 
 
 
Other Expenses0.000.00-3.2K-1.6K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-248.3K-827.2K-1.5M-4.6M
 
 
 
 
 
Net Income-248.3K-827.2K-1.5M-4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.7M15.1M16.9M25.4M
 
 
 
 
 
Shares To Calculate EPS Diluted10.7M15.1M16.9M25.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.05-$0.09-$0.18
 
 
 
 
 
EPS Diluted-$0.02-$0.05-$0.09-$0.18
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account